Data protection Impressum

Financing

SOPHiA GENETICS, the Lausanne-based leader in AI-driven precision medicine, has closed an oversubscribed public offering with gross proceeds of USD 57.5 million to expand its platform, applications and partnerships.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

22 June 2026

The Swiss Deeptech Report 2026 ranks Switzerland first in the world for the share of venture capital flowing to deeptech and first in Europe per capita, with EPFL in Lausanne named among Europe's two leading universities for deeptech spinouts.

Switzerland leads the world in deeptech venture funding in 2026

17 June 2026

ZAAN, the Geneva- and Shenzhen-based contract-intelligence platform, has raised USD 5 million from Tencent Investment to develop its AI engines, broaden language and jurisdiction coverage, and grow its teams.

Geneva legaltech start-up ZAAN raises USD 5 million from Tencent

17 June 2026

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

The Foundation for Innovation and Technology has awarded three Tech Seed loans of CHF 100,000 each to EM Path, REMA and Verretex, and a CHF 20,000 Digital Grant to Polytax.

Business environment

The FIT awards loans and a grant to four Western Switzerland start-ups

15 June 2026

Lausanne-based preemptive identity security start-up Saporo is partnering with Columbus-based venture OH.io to lead its expansion into North America, becoming the first international company in OH.io's portfolio.

Saporo partners with OH.io to expand into the North American market

15 June 2026

Geneva-based MindMaze Therapeutics announced a CHF 8 million strategic equity financing from Neuro.io Group, funding the expansion of its U.S. commercial operations and opening the door to a potential combination of neurotherapeutics and artificial intelligence.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

1 June 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (May 2026)

27 May 2026

Prilly’s Visium has raised its first institutional round, backed by Columbus Venture Partners, Concentric, and prominent AI unicorn founders.

Visium lands first institutional round to scale AI in regulated industries

27 May 2026

1 2 3 4 5 6 7 8 9 … 34